Companies › Healthcare

DexCom DXCM

HealthcareMarket cap $25B3 connections

DexCom makes continuous glucose monitors worn by millions of diabetics. Its G7 sensor transmits blood sugar readings to a smartphone every 5 minutes, eliminating finger pricks. CGM adoption is expanding from Type 1 to Type 2 diabetics - a 10x larger market - and even to health-conscious non-diabetics.

Explore DexCom on the interactive map Relationship timeline Find a path to another company

Partners 3

Strategic partnerships, joint products and alliances

  • AppleTechnology · $3.0TDexCom CGM glucose data on Apple Watch
  • Abbott LabsHealthcare · $200BCompeting CGMs - DexCom vs Abbott FreeStyle Libre
  • Insulet CorporationHealthcare · $12BOmnipod integrates with Dexcom CGM sensors

Competitors 1

Companies it competes with

Key relationships in depth

DexCom & Apple

DexCom's G7 continuous glucose monitor displays real-time blood glucose readings directly on Apple Watch without requiring a separate phone interaction, a feature announced with Apple Watch Series 9 in 2023. Diabetic and pre-diabetic users can see glucose data in Watch complications and the Health app, and share readings with physicians through Apple Health Records integration.

Why it matters: The integration positions Apple Watch as a clinical health management device beyond fitness tracking, targeting the 37M diabetic and 96M pre-diabetic Americans. For DexCom, Apple Watch is a high-value distribution channel reaching tech-forward health-conscious users. Apple Health's secure data platform enables clinical-grade data sharing workflows.

Other Healthcare companies

Embed this on your site

Show DexCom's network in an article or report - it updates as our data does.

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.